drug companies


The 21st Century Cures Bill: Transparency Win Isn’t Enough

, Washington representative, Center for Science and Democracy

In the midst of one of the most abnormal presidential transitions in history, Congress is spending its last few weeks of session to wrap up pending business. One of the final remaining priorities for House and Senate leaders is the 21st Century Cures Act (Cures Act). Read more >

Bookmark and Share

Dr. Frances Oldham Kelsey’s Legacy for Science and Democracy

, former analyst, Center for Science & Democracy

On August 7, 2015, Dr. Frances Oldham Kelsey passed away at the age of 101. Dr. Kelsey—a true hero of science and democracy—championed science-based policies that protected public health and safety throughout her life. Most famously, her actions preventing the FDA approval of thalidomide—a drug that causes birth defects—stopped what could have been a devastating tragedy for Americans. As my colleague Celia Wexler wrote, “The lesson of thalidomide is that regulations matter.” Read more >

Bookmark and Share

Putting the Interests of Patients First: Conference Endorses Science-Focused Health Care

, sr. Washington rep., Center for Science & Democracy

It’s not often that some of the best and most creative minds in medicine, medical ethics and healthcare all gather in one place. It’s even more rare when all these individuals are gathered together to focus on one problem—undue corporate influence on the treatment of patients in the U.S. Read more >

Bookmark and Share